In Turkey, the fresh fruit juice of Ecbalium elaterium (Cucurbitaceae)
is directly applied into nostrils for the treatment of sinusitis. Cli
nical tests on voluntary patients revealed that the healing rate of do
uble-high dosage application is higher than that of the single-low dos
age (71.0 and 56.6%, respectively). In addition, a total relief from t
he main symptoms is observed in 20% of the patients, although the sinu
ses are not completely drained off on X-ray examination. As the next s
tep, the active anti-inflammatory principle which might be responsible
for its activity is isolated through the fraction of the fruit juice
with solvent extraction and preparative tlc. For the fractionation pro
cess, the effects of the fractions on increased vascular permeability
induced by AcOH in mice are used and the structure of the active anti-
inflammatory principle thus obtained is elucidated as cucurbitacin B.
Further studies are conducted to evaluate the anti-inflammatory activi
ty of cucurbitacin B using serotonin- and bradykinin-induced edemas in
mice. On the other hand, cucurbitacin B content in the juice is deter
mined as 2.48% by HPLC.